1. Home /
  2. Natural Gas

Natural Gas

Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.

Eli LIlly Beats, Sears Cuts Whirlpool: Tuesday's Top Stories

Top stories today: Eli Lilly is raising its projections for the entire year since its newer drugs are doing well, Sears stops selling Whirlpool appliances in their stores and President Trump meets with lawmakers to discuss tax reform.

Dr. Oz Welcomes Amazon's Desires to Enter the Pharmacy Business

Famed television host Dr. Oz supports Amazon's potential move into the pharmacy business, pointing to the company's track record of lowering prices for consumers.

Jim Cramer Reveals One Part of Schlumberger's Results That 'Freaked People Out'

Schlumberger shares are down 25% since the start of the year.

Gilead Sciences Yescarta Drug Approved By FDA

Shares of Gilead Sciences rose 2% Thursday after the FDA approved its Yescarta lymphoma cancer therapy drug.

Amazon's HQ2, Cancer Therapy Approved: Thursday's Top Stories

Today's Top Stories: Amazon's deadline to submit a proposal to build a new headquarters is today, Gilead shares are jumping as a result of the FDA's approval of a cancer treatment, today marks the 30th anniversary of Black Monday.

Lysol and Clearasil Are Among the Brand You Didn't Know Reckitt Benckiser Owns

The British consumer goods company is behind some of the most well-known brands on your supermarket's shelf including Veet, Lysol and Clearasil.

UnitedHealth and Insurance Agreement Lead Dow, S&P 500 to Records

The Dow ended the day at all-time highs for its second session in a row, though missed out on ending above that 23,000 mark it hit earlier.

Allergan Is the 'Cheapest Big-Cap Drug Stock in the Universe': Cramer

Stockpicker plans to buy more AGN if it drops another $5 or so.

Dow Powers to New Record, Nears 23,000

The Dow, the Nasdaq and the S&P 500 all reached new record highs even though drug stocks were under pressure following comments by President Trump.